Business Trip The quest to improve MDMA
Dec 20, 2022
This podcast explores the development of new psychedelic compounds, the therapeutic potential of MDMA, and the challenges of running a psychedelic biotech company. It also discusses the potential applications and administration methods of psychedelic compounds, as well as initiatives to improve access to MDMA. Additionally, it delves into the rush of biotech companies going public and the concept of founder equity pledge in the psychedelic research field.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 5min
Exploring the Therapeutic Potential of MDMA
05:12 • 24min
Potential Applications and Administration of Psychedelic Compounds
29:28 • 18min
Expanding Access to MDMA and Collective Action
46:59 • 2min
Meeting the Co-founder and Challenges in Running a Psychedelic Biotech
48:51 • 2min
Biotech Companies Going Public and Founder Equity Pledge
51:00 • 4min